Here's Why Clearside Biomedical (CLSD) Is a Great 'Buy the Bottom' Stock Now
Werte in diesem Artikel
Shares of Clearside Biomedical, Inc. (CLSD) have been struggling lately and have lost 5.6% over the past two weeks. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock. Understanding Hammer Chart and the Technique to Trade ItThis is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.'In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price.When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal.Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors.Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators.Here's What Makes the Trend Reversal More Likely for CLSDAn upward trend in earnings estimate revisions that CLSD has been witnessing lately can certainly be considered a bullish indicator on the fundamental side. That's because empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.Over the last 30 days, the consensus EPS estimate for the current year has increased 14%. What it means is that the sell-side analysts covering CLSD are majorly in agreement that the company will report better earnings than they predicted earlier.If this is not enough, you should note that CLSD currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Moreover, a Zacks Rank of 2 for Clearside Biomedical is a more conclusive indication of a potential trend reversal, as the Zacks Rank has proven to be an excellent timing indicator that helps investors identify precisely when a company's prospects are beginning to improve.Zacks Naming Top 10 Stocks for 2025Want to be tipped off early to our 10 top picks for the entirety of 2025?History suggests their performance could be sensational.From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2025. Don’t miss your chance to get in on these stocks when they’re released on January 2.Be First to New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Clearside Biomedical, Inc. (CLSD): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Clearside Biomedical
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Clearside Biomedical
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Clearside Biomedical Inc
Analysen zu Clearside Biomedical Inc
Datum | Rating | Analyst | |
---|---|---|---|
09.08.2019 | Clearside Biomedical Hold | Needham & Company, LLC | |
05.11.2018 | Clearside Biomedical Hold | Stifel, Nicolaus & Co., Inc. | |
05.11.2018 | Clearside Biomedical Market Perform | Cowen and Company, LLC | |
06.03.2018 | Clearside Biomedical Buy | Needham & Company, LLC | |
10.11.2016 | Clearside Biomedical Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
05.11.2018 | Clearside Biomedical Hold | Stifel, Nicolaus & Co., Inc. | |
06.03.2018 | Clearside Biomedical Buy | Needham & Company, LLC | |
10.11.2016 | Clearside Biomedical Buy | Needham & Company, LLC | |
24.10.2016 | Clearside Biomedical Buy | Stifel, Nicolaus & Co., Inc. | |
28.06.2016 | Clearside Biomedical Buy | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
09.08.2019 | Clearside Biomedical Hold | Needham & Company, LLC | |
05.11.2018 | Clearside Biomedical Market Perform | Cowen and Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Clearside Biomedical Inc nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen